Bicara Therapeutics Inc. (BCAX) — Stock Score Summary

Bicara Therapeutics Inc. (BCAX) has a MoatMap StockRank of 54/100 based on Quality (42/100), Value (38/100), and Momentum (60/100) factor scores. The current signal is HOLD. Bicara Therapeutics is a clinical-stage biotechnology company. It lacks commercialized products, positive owner earnings, and a proven business model, making it too speculative for our quality-focused investment philosophy.

Bicara Therapeutics Inc. is a clinical-stage biotechnology company developing novel bifunctional therapeutics for cancer treatment. Its unique approach combines targeted drug delivery with immune stimulation, aiming for enhanced efficacy and reduced toxicity. Bicara is a niche biotech focused on innovative oncology drug development with a distinct mechanism of action.

Key Financial Metrics

Price$20.56
Market Cap$1.4B
P/E (Forward)-5.62
Price/Book2.60
Return on Equity-32.3%
Return on Invested Capital-38.7%
Debt/Equity0.28
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-68M

Bicara Therapeutics Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Bicara Therapeutics Inc.’s (BCAX) StockRank?
MoatMap’s StockRank for Bicara Therapeutics Inc. (BCAX) is 54/100, with a Hold signal. It is a composite of Quality (42), Value (38), and Momentum (60) factor ranks across MoatMap’s 19,000+ stock universe.
Does Bicara Therapeutics Inc. have an economic moat?
Bicara Therapeutics Inc. (BCAX) has a Quality factor score of 42/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Bicara Therapeutics Inc. a buy, hold, or sell?
MoatMap’s current signal for Bicara Therapeutics Inc. (BCAX) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Bicara Therapeutics Inc. in?
Bicara Therapeutics Inc. (BCAX) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksBCAX deep dive reportAI ChampionsHow we score stocksSense-check another stock